All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

19

Reset

19 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • KN057Phase 34 trials

    Suzhou Alphamab Co., Ltd. · Hemophilia A Without Inhibitor, Hemophilia B Without Inhibitor, Hemophilia a and B

  • SR604Phase 34 trials

    Shanghai RAAS Blood Products Co., Ltd. · Factor VII Deficiency, Hemophilia A, Hemophilia B

  • BIVV001efanesoctocog, AltuvoctPhase 33 trials

    Swedish Orphan Biovitrum · Haemophilia A (Moderate or Severe), Hemophilia A, Hemophilia A, Severe

  • bypassing agentsClotting factor concentrates, CFCPhase 33 trials

    Sanofi · Hemophilia, Von Willebrand Disease, Type 3

  • FRSW107Phase 33 trials

    Hangzhou Gensciences Biopharmaceutical Co., Ltd. · Severe Hemophilia A

  • GS1191-0445Phase 32 trials

    Gritgen Therapeutics Co., Ltd. · Severe Hemophilia A, Hemophilia A

  • NXT007Zemocimig, RO7589655Phase 32 trials

    Roche (Genentech) · Hemophilia A

  • Valoctocogene roxaparvovecBMN 270, GENEr8Phase 32 trials

    BioMarin · Hemophilia A, Hemophilia A With Inhibitor, Hemophilia A With Anti Factor VIII

  • FRSW117Recombinant human coagulation factor Ⅷ-Fc fusion proteinPhase 31 trial

    Hangzhou Gensciences Biopharmaceutical Co., Ltd. · Severe Hemophilia A

  • PF-06838435fidanacogene elaparvovecPhase 31 trial

    Pfizer · Hemophilia B

  • SKP-0141Phase 31 trial

    SK Plasma Co., Ltd. · Hemophilia A, Severe

  • STSP-0601Phase 31 trial

    Jiangsu BioJeTay Biotechnology Co., Ltd. · Hemophilia

  • ARD001Phase 21 trial

    Arditus Pte Ltd · Hemophilia A, Healthy Adult Participants

  • ASC618Phase 21 trial

    ASC Therapeutics · Hemophilia A

  • AskBio009BAX 335Phase 21 trial

    Takeda · Hemophilia B

  • BAY2599023DTX201Phase 21 trial

    Bayer · Hemophilia A

  • LNP1265Phase 21 trial

    Regeneron · Hemophilia B

  • REGV131Phase 21 trial

    Regeneron · Hemophilia B

  • SPK-8011QQRO7878488Phase 21 trial

    Roche (Genentech) · Hemophilia A

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.